Effect and Mechanism of ShiZhiFang on Uric Acid Metabolism in Hyperuricemic Rats

Abstract EN

Objective.

To explore the effect and mechanism of ShiZhiFang on uric acid metabolism.

Methods.

40 rats were divided into normal group, model group, ShiZhiFang group, and benzbromarone group.

The hyperuricemic rat model was induced by yeast gavage at 15 g/kg and potassium oxonate intraperitoneal injection at 600 mg/kg for two weeks.

During the next two weeks, ShiZhiFang group rats were given ShiZhiFang by gavage, and benzbromarone group rats were given benzbromarone by gavage.

The serum uric acid, creatinine, blood urea nitrogen, XOD activity, urinary uric acid, urinary β 2-MG, and histopathological changes were observed in the rats of each group after treatment.

Results.

The hyperuricemic model was established successfully and did not show the increase of serum creatinine and blood urea nitrogen.

Compared with the model group, the serum uric acid, serum XOD activity, and urinary β 2-MG were significantly decreased ( p < 0.05 ), and 24 h urinary uric acid excretion was significantly decreased ( p < 0.0 1 ) in ShiZhiFang group, whereas the two treatment groups were of no statistical significant in above indicators ( p > 0.05 ); renal histopathology showed that the lesions in two treatment groups were reduced compared to the model groups.

The gene and protein expression of uric acid anion transporters rOAT1 and rOAT3 in the kidney was significantly higher than that in model group ( p < 0.01 ).

Conclusion.

The model is suitable for the study of primary hyperuricemia.

The mechanisms of ShiZhiFang on uric acid metabolism in hyperuricemic rats may be involved in reducing the activity of serum XOD and promoting the transcription and expression of rOAT1 and rOAT3 in the kidney.